(lp0
S"FBR Reiterates Buy On Arena Pharmaceuticals, Inc.  Following 4Q16 Update Smarter Analyst - Mar 15, 2017 In a research report published Wednesday, FBR analyst Rahul Jasuja reiterated an Outperform rating on shares of Arena Pharmaceuticals, Inc.  with a price target of $6.00, following the company's fourth-quarter results and update on its&nbsp;...Arena Pharmaceuticals  Posts Q4 Earnings, Revenues Up - Yahoo FinanceArena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and ... - PR Newswire "
p1
aS"Arena Pharmaceuticals  Q4 Earnings: What to Expect? Yahoo Finance - Feb 27, 2017 Arena Pharmaceuticals, Inc. ARNA is expected to report fourth-quarter 2016 results next month. The company delivered a positive earnings surprise of 28.57% last quarter.What's On Focus As Arena Pharmaceuticals, Inc.  Reports Q4? - StockNewsUnion"
p2
aS'3 Stocks to Watch on Wednesday: Bank of America Corp , Arena ... Investorplace.com - Mar 15, 2017 Arena Pharmaceuticals, Inc.  and Fogo De Chao Inc  are among a few companies moving big-time on earnings this morning, though Bank of America Corp  might save its moving and shaking for this afternoon.'
p3
aS'Arena Pharmaceuticals to Present at the 27th Annual Oppenheimer Healthcare ... PR Newswire  - Mar 8, 2017 SAN DIEGO, March 8, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that Amit Munshi, the&nbsp;...'
p4
aS'Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter ... GlobeNewswire  - Mar 6, 2017 SAN DIEGO, March 06, 2017  -- Arena Pharmaceuticals, Inc. , today announced that the Company will provide a corporate update and release its fourth quarter and full-year 2016 financial results on Tuesday, March 14,&nbsp;...Arena Pharmaceuticals, Inc.  Stock Rating Decreased by the Zacks ... - Petro Global News 24Today Arena Pharmaceuticals, Inc.  Receives Consensus Rating of Hold ... - DailyQuint'
p5
aS"United States: Schueneman V. Arena Pharmaceuticals, Inc.: Federal Appeals ... Mondaq News Alerts  - Feb 20, 2017 On 26 October 2016, in Schueneman v. Arena Pharmaceuticals, Inc., the federal appeals court based in California reversed the lower court's dismissal of claims brought under the Exchange Act for failure to plead scienter (i."
p6
aS'Notable Buzzer: Arena Pharmaceuticals, Inc.  Is stories - Mar 17, 2017 ARNA has received different ratings from analysts, according to FactSet. Recently the stock has been recommended as Buy from 3 and 0 suggested Sell for the stock.'
p7
aS'Arena Pharmaceuticals Inc Risk Points versus Health Care CML News - Mar 15, 2017 This is a scatter plot analysis of the critical risk points from the option market for Arena Pharmaceuticals Inc  compared to its own past and the Health Care ETF.'
p8
aS'Eye Catching Stocks Arena Pharmaceuticals, Inc. , Invesco Ltd ... Normangee Star - 17 hours ago Arena Pharmaceuticals, Inc.is expected to give up sales by -32.67% in next year to $35.49M. Studies indicate that the stock prices of firms with significant positive earnings surprises show above-average performance, while those with negative surprises ...'
p9
aS'Stock Returns: Arena Pharmaceuticals Inc  versus Sinovac Biotech ... CML News - Feb 28, 2017 This is a snapshot to compare the stock returns for Arena Pharmaceuticals Inc  versus Sinovac Biotech Ltd.  .'
p10
a.